Methyl Tanshinonate

Methyl Tanshinonate

SCHEMBL14417730

COC(=O)[C@@]1(C)CCCc2c1ccc1c2C(=O)C(=O)c2c(C)coc2-1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EED O75530 5/20 1.00
▸ SUZ12 Q15022 5/20 1.00
▸ EZH2 Q15910 5/20 1.00
▸ HIF1A Q16665 2/20 1.00
▸ EPAS1 Q99814 2/20 1.00
▸ KDM4E B2RXH2 1/20 0.70
▸ MEN1 O00255 1/20 0.70
▸ CES2 O00748 1/20 0.70
▸ APAF1 O14727 1/20 0.70
▸ TERT O14746 1/20 0.70
▸ ALDH1A1 P00352 1/20 0.70
▸ LMNA P02545 1/20 0.70
▸ TP53 P04637 1/20 0.70
▸ POLB P06746 1/20 0.70
▸ MAPT P10636 1/20 0.70
▸ AKR1B1 P15121 1/20 0.70
▸ HPGD P15428 1/20 0.70
▸ ALOX12 P18054 1/20 0.70
▸ CES1 P23141 1/20 0.70
▸ APEX1 P27695 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Tanshinonate SCHEMBL16152293 1.00 EED (1.00) EEDSUZ12EZH2HIF1AEPAS1
SCHEMBL16152326 0.83 EED (0.78) EEDSUZ12EZH2HIF1AEPAS1
Tanshinone Iia SCHEMBL2026738 0.83 EED (1.00) EEDSUZ12EZH2HIF1AEPAS1
SCHEMBL17663613 0.80 EED (0.77) EEDSUZ12EZH2HIF1AEPAS1
Tanshinone Iib SCHEMBL11945767 0.80 EED (1.00) EEDSUZ12EZH2HIF1AEPAS1
SCHEMBL14417696 0.78 EED (0.76) EEDSUZ12EZH2HIF1AEPAS1
SCHEMBL16152283 0.78 EED (0.76) EEDSUZ12EZH2HIF1AEPAS1
SCHEMBL29538928 0.75 EED (0.84) EEDSUZ12EZH2HIF1AEPAS1
SCHEMBL16023777 0.75 EED (0.84) EEDSUZ12EZH2HIF1AEPAS1
SCHEMBL30923422 0.74 IDO1 (1.00) EEDSUZ12EZH2HIF1AEPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119380826-B Chinese patent medicine network pharmacology analysis method and model construction method based on multiscale information entropy 首都医科大学附属北京朝阳医院 2025-04-08 — — CN disclosed
CN-119380826-A Chinese patent medicine network pharmacology analysis method and model construction method based on multiscale information entropy 首都医科大学附属北京朝阳医院 2025-01-28 — — CN disclosed
US-20240374666-A1 COMPOSITIONS FOR PREVENTING AND/OR REDUCING VIRAL INFECTION FIRMENICH SA (CH) 2024-11-14 — — US disclosed
US-20230390352-A1 COMPOSITION COMPRISING SALVIA MILTIORRHIZA EXTRACT AS ACTIVE INGREDIENT FOR PREVENTION AND TREATMENT OF DEPRESSION IN MENOPAUSAL WOMEN UNDBIO.CO.,LTD (KR) 2023-12-07 — — US disclosed
WO-2023057474-A1 COMPOSITIONS FOR PREVENTING AND/OR REDUCING VIRAL INFECTION FIRMENICH SA (CH) 2023-04-13 — — WO disclosed
CN-109485691-B Tanshinone compound and application thereof in treating hemangioma 上海交通大学医学院附属新华医院 2023-04-11 — — CN disclosed
US-20070207989-A1 DITERPENE DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR, CANCER AND INFLAMMATORY DISEASES SAVIPU PHARMACEUTICALS (US) 2007-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070207989-A1 DITERPENE DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR, CANCER AND INFLAMMATORY DISEASES NFKBIA, EDNRA, EDNRB EED 2840/4885SUZ12 1953/4885EZH2 4158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback